Imiraft Oral Suspension Mint Sugar Free is a medicinal formulation containing Calcium Carbonate (80 mg), Sodium Alginate (250 mg), and Sodium Bicarbonate (133.5 mg) per dose, designed for the symptomatic relief of gastroesophageal reflux disease (GERD), heartburn, and indigestion. Calcium Carbonate acts as an effective antacid, neutralizing excess gastric acid to provide rapid relief from acidity and associated discomfort. Sodium Alginate forms a viscous gel that floats on the gastric contents, creating a physical barrier to prevent acid reflux into the esophagus, thereby reducing irritation and promoting mucosal healing. Sodium Bicarbonate contributes to acid neutralization, enhancing the overall antacid effect and providing prompt symptom alleviation. The mint-flavored, sugar-free oral suspension formulation ensures ease of administration and improved patient compliance, particularly suitable for individuals requiring sugar-free medication. Imiraft is indicated for adults and children over a specified age, under medical guidance, for short-term management of acid-related gastrointestinal conditions. It is important to adhere to recommended dosages and consult a healthcare professional before use, especially in patients with renal impairment, cardiovascular conditions, or those on concurrent medications, to avoid potential adverse effects or interactions. This preparation offers a balanced approach to managing acid reflux symptoms through combined pharmacological mechanisms.